Buxifoliadine A has shown potential in pharmacological research due to its structural complexity and bioactivity. It exhibits notable cytotoxic properties, making it a candidate for anticancer studies. Preliminary in vitro tests indicate activity against certain tumor cell lines, suggesting possible use in developing chemotherapeutic agents. Its mechanism may involve interaction with cellular proteins or disruption of mitochondrial function, though exact pathways remain under investigation. Additionally, it has demonstrated mild antimicrobial effects, warranting further exploration for use in infectious disease treatment. Due to its natural origin and unique alkaloid structure, it also serves as a lead compound for synthetic modification to enhance potency and reduce toxicity.